Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Carpita

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacological Research|July 1, 1991
A new low molecular weight heparan sulphate antagonizes kappa-carrageenan-induced thrombosis in ratsG B Gervasi, C Bartoli, G Carpita
Arzneimittel-Forschung|September 1, 1988
Decrease of bleeding time by a peptide fraction from bovine factor VIII in laboratory animalsG B Gervasi, C Bartoli, G Carpita, et al.
Arzneimittel-Forschung|April 1, 1993
Disposition of a new heparan sulfate with fibrinolytic activity in the ratG B Gervasi, C Farina, C Bartoli, et al.
Arzneimittel-Forschung|April 1, 1991
Some chemical and biological properties of the low molecular weight heparan sulfate alpha-idosaneG B Gervasi, C Bartoli, C Farina, et al.
Pharmacological Research|June 1, 1995
A comparison of the activity of a heparan sulphate of defined molecular weight range (7500-15,000 Da) with heparin and dermatan sulphateG B Gervasi, R Catalani, C Bartoli, et al.
Arzneimittel-Forschung|November 1, 1991
Effects of a new aldose reductase inhibitor on diabetic complications in ratsG B Gervasi, C Bartoli, R Catalani, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacological Research|July 1, 1991
A new low molecular weight heparan sulphate antagonizes kappa-carrageenan-induced thrombosis in ratsG B Gervasi, C Bartoli, G Carpita
Arzneimittel-Forschung|September 1, 1988
Decrease of bleeding time by a peptide fraction from bovine factor VIII in laboratory animalsG B Gervasi, C Bartoli, G Carpita, et al.
Arzneimittel-Forschung|April 1, 1993
Disposition of a new heparan sulfate with fibrinolytic activity in the ratG B Gervasi, C Farina, C Bartoli, et al.
Arzneimittel-Forschung|April 1, 1991
Some chemical and biological properties of the low molecular weight heparan sulfate alpha-idosaneG B Gervasi, C Bartoli, C Farina, et al.
Pharmacological Research|June 1, 1995
A comparison of the activity of a heparan sulphate of defined molecular weight range (7500-15,000 Da) with heparin and dermatan sulphateG B Gervasi, R Catalani, C Bartoli, et al.
Arzneimittel-Forschung|November 1, 1991
Effects of a new aldose reductase inhibitor on diabetic complications in ratsG B Gervasi, C Bartoli, R Catalani, et al.
Pageof 1